Olaparib in German routine clinical practice: Updated interim results of the non-interventional study C-PATROL.

被引:4
|
作者
Marme, Frederik
Hilpert, Felix
Welslau, Manfred
El-Balat, Ahmed
Grischke, Eva-Maria
Schinkothe, Timo
Glowik, Regina
Sehouli, Jalid
机构
[1] Heidelberg Univ, Natl Ctr Tumor Dis, Dept Gynecol, Heidelberg, Germany
[2] Onkolog Therapiezent Krankenhaus Jerusalem, Hamburg, Germany
[3] Hematol Oncol Practice, Aschaffenburg, Germany
[4] Univ Hosp Frankfurt, Frankfurt, Germany
[5] Univ Frauenklin Tubingen, Eberhard Karls Univ, Tubingen, Germany
[6] Inst Innovat & Med, Munich, Germany
[7] AstraZeneca GmbH, Wedel, DE USA
[8] Charite Med Univ, Dept Gynecol, Campus Virchow Clin, Berlin, Germany
关键词
D O I
10.1200/JCO.2018.36.15_suppl.e17549
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17549
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Glowik, R.
    Marme, F.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 120 - 120
  • [2] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 510 - 510
  • [3] Olaparib in German routine clinical practice - Interim results of the non-interventional study C-PATROL
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Fasching, P. A.
    El-Balat, A.
    Glowik, R.
    Marme, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [4] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1590 - 1590
  • [5] Results of the second interim analysis of C-PATROL: A non-interventional study on olaparib within German routine clinical practice
    Marme, F.
    Hilpert, F.
    Welslau, M.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A. D.
    Glowik, R.
    Sehouli, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 250 - 251
  • [6] Results of the 3rd interim analysis of C-Patrol: A non-interventional study on olaparib in German routine clinical practice
    Sehouli, J.
    Hilpert, F.
    Welslau, M. K.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A.
    Glowik, R.
    Marme, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 412 - 412
  • [7] RESULTS OF THE 3RD INTERIM ANALYSIS OF C-PATROL: A NON-INTERVENTIONAL STUDY ON OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE
    Marme, F.
    Hilpert, F.
    Welslau, M.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A. D.
    Glowik, R.
    Sehouli, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A144 - A144
  • [8] Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study
    El-Balat, A.
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Grabowski, J. P.
    Hartkopf, A.
    Glowik, R.
    Hilpert, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E188 - E188
  • [9] Olaparib routine clinical practice in Germany - Interim results of the non-interventional C-PATROL study reflecting routine BRCA mutational testing
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Grischke, E. M.
    Glowik, R.
    Marme, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 87 - 87
  • [10] Olaparib Routine Clinical Practice in Germany - Interim Results of The Non-Interventional C-Patrol Study with a Focus on Patients who Switched from The Olaparib Capsule to the Tablet Formulation
    Grabowski, Jacek P.
    Marme, Frederik
    Hilpert, Felix
    Welslau, Manfred
    Hartkopf, Andreas
    El-Balat, Ahmed
    Glowik, Regina
    Sehouli, Jalid
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 88 - 88